Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

Phenacetin

Alternative Names: phenacetin
Clinical Status: Inactive
Latest Update: 2024-05-12
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: COX1 Inhibitor,COX2 Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: *

Approval Status: Not Approved

Approved Countries: Chile | China | Hungary | Ireland | Mexico | New Zealand | Pakistan | South Africa | Taiwan

Approved Indications: None

Known Adverse Events: None

Company: Center for Epidemiology and Health Research, Germany
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated
ChiCTR2300074946

N/A

Not yet recruiting

Unknown

2023-12-31

2024-01-20

NCT00302835

N/A

Completed

Kidney Failure, Chronic

None

2019-03-21

Treatments

Recent News Events

Date

Type

Title

05/12/2024

PubMed

 Phenacetin promoted the rapid start-up and stable maintenance of partial nitrification: Responses of nitrifiers and antibiotic resistance genes.

05/10/2024

PubMed

 Development and validation of HPLC-ultraviolet method for quantitative determination of pritelivir in human placental perfusion medium.

04/28/2024

PubMed

 Effects of electroacupuncture on treatment-resistant chronic migraine with medication overuse headache: A 12-month follow-up case report.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions